ReNerve Limited

A$0.08As of Sun 8 Nov 2026, 12:00 UTC
ASX:RNVHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (133.13%)
Biotechnology
Beta (5Y) 0.65
PE TTM —
TSR TTM (20.00%)
Mkt cap A$13.78M
ROIC (95.01%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.102
27.20%
(54.60%)
Hold 0|4|6|9|6
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
27.83%
33.52%
17.01%
8.76%
Revenue$M
0.809
0.850
0.834
0.826
5.67%
8.83%
4.36%
1.68%
Peers (US$9.467M)
Cap (US$)
PE
8.797M
—
Capital
TTM
5Y
10Y
Leveragex
1.152
(0.033)
(0.031)
EBIT/Intx
1.604
0.252
0.238
Own earn%
55.47
30.58
28.20
Sh yield%
11.21
31.72
33.64
Owners
Insiders/Inst%
10.43
49.13
Short interest%
3.34
SBC / revenue%
2.88
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
19–28
$1 testx
−0.1
Incr. ROIC%
4